Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May-Jun;25(3):137-41.
doi: 10.5830/CVJA-2014-014.

Novel cardiovascular risk markers in women with ischaemic heart disease

Dana Pop  1 , Alexandra Dădârlat  2 , D Zdrenghea  2
Affiliations
Review

Novel cardiovascular risk markers in women with ischaemic heart disease

Dana Pop et al. Cardiovasc J Afr. 2014 May-Jun.

Abstract

The incidence of coronary heart disease in premenopausal women is lower than in men because of their hormonal protection. Angina pectoris occurs in women about 10 years later than in men. However, mortality from ischaemic heart disease remains higher in women than in men. Current studies are focusing on novel cardiovascular risk biomarkers because it seems that traditional cardiovascular risk factors and their assessment scores underestimate the risk in females. Increased plasma levels of these newly established biomarkers of risk have been found to worsen endothelial dysfunction and inflammation, both of which play a key role in the pathogenesis of microvascular angina, which is very common in women. These novel cardiovascular risk markers can be classified into three categories: inflammatory markers, markers of haemostasis, and other biomarkers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Newby LK, Douglas PS. Cardiovascular disease in women. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 9th edn. Ed Saunders; 2011. pp. 1757–1769.
    1. Mosca L, Benjamin EJ, Berra K. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243–1262. - PMC - PubMed
    1. Alfonso F, Bermejo J, Segovia J. Cardiovascular disease in women. Why now? Rev Esp Cardiol. 2006;59:259–263. - PubMed
    1. Stramba-Badiale M, Fox KM, Priori SG. et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J. 2006;27:994–1005. - PubMed
    1. Wenger NK, Shaw LJ, Vaccarino V. Coronary heart disease in women: update 2008. Clin Pharmacol Ther. 2008;83:37–51. - PubMed

LinkOut - more resources